Cargando…
Effect of RAS status on anti-EGFR monoclonal antibodies + 5-FU infusion-based chemotherapy in first-line treatment of metastatic colorectal cancer: A meta-analysis
PURPOSE: To investigate the effect of RAS on anti-EGFR moAb + 5-FU infusion based chemotherapy in first-line treatment of mCRC. METHODS: The MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, Cochrane databases and ClinicalTrials.gov databases were independently reviewed. Primary end p...
Autores principales: | Zhou, Mingyi, Yu, Ping, Hou, Kezuo, Fu, Lingyu, Chen, Ying, Qu, Jinglei, Qu, Xiujuan, Liu, Yunpeng, Zhang, Jingdong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908286/ https://www.ncbi.nlm.nih.gov/pubmed/27331015 http://dx.doi.org/10.1016/j.mgene.2016.05.001 |
Ejemplares similares
-
β-Elemene-induced autophagy protects human gastric cancer cells from undergoing apoptosis
por: Liu, Jing, et al.
Publicado: (2011) -
A Prognostic Model in Metastatic or Recurrent Gastric Cancer Patients with Good Performance Status Who Received First-Line Chemotherapy()
por: Wang, Jin, et al.
Publicado: (2016) -
Phase III Trials of Standard Chemotherapy with or without Bevacizumab for Ovarian Cancer: A Meta-Analysis
por: Zhou, Mingyi, et al.
Publicado: (2013) -
A novel function of hepatocyte growth factor in the activation of checkpoint kinase 1 phosphorylation in colon cancer cells
por: Song, Na, et al.
Publicado: (2017) -
5-FU-Induced Upregulation of Exosomal PD-L1 Causes Immunosuppression in Advanced Gastric Cancer Patients
por: Zhang, Min, et al.
Publicado: (2020)